• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Incyte Corporation (INCY)

    -NasdaqGS
    70.91 Down 0.09(0.13%) Feb 8, 4:00PM EST
    Prev Close:71.00
    Open:69.50
    Bid:65.91 x 100
    Ask:113.99 x 1300
    1y Target Est:113.69
    Beta:0.68688
    Next Earnings Date:11-Feb-16INCY Earnings announcement
    Day's Range:65.61 - 71.70
    52wk Range:64.51 - 133.62
    Volume:3,376,360
    Avg Vol (3m):1,919,570
    Market Cap:13.19B
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 0.13%13.19B
    CELGUp 1.32%77.92B
    AMGNDown 1.41%107.82B

    Key Statistics

    Forward P/E (1 yr):122.26
    P/S (ttm):20.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Dec-15) :0.09
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-7.00

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback